TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
NXTC Stock 12 Month Forecast
Average Price Target
$17.67
▲(65.14% Upside)
Based on 3 Wall Street analysts offering 12 month price targets for NextCure in the last 3 months. The average price target is $17.67 with a high forecast of $20.00 and a low forecast of $15.00. The average price target represents a 65.14% change from the last price of $10.70.
Promising Advancements and Strategic Partnerships Drive Buy Rating for NextCureValuation and Risks. Our Buy rating and $20 price target are based on a discounted cash flow analysis (DCF). In our DCF, we extend our estimates to 2040 and assign a 12% discount rate and no terminal value. We currently assume value for LNCB74 for treatment of TNBC with 25% POS. We view additional indications in development as upside to our price target.
Promising Advancements and Strategic Partnerships Drive Buy Rating for NextCureValuation and Risks. Our Buy rating and $20 price target are based on a discounted cash flow analysis (DCF). In our DCF, we extend our estimates to 2040 and assign a 12% discount rate and no terminal value. We currently assume value for LNCB74 for treatment of TNBC with 25% POS. We view additional indications in development as upside to our price target.
trades and holding each position for 1 Month would result in 41.67% of your transactions generating a profit, with an average return of -8.38% per trade.
trades and holding each position for 3 Months would result in 53.85% of your transactions generating a profit, with an average return of -1.34% per trade.
Copying Emily Bodnar's trades and holding each position for 1 Year would result in 46.15% of your transactions generating a profit, with an average return of -0.15% per trade.
trades and holding each position for 2 Years would result in 38.46% of your transactions generating a profit, with an average return of -0.05% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
NXTC Analyst Recommendation Trends
Rating
Apr 25
May 25
Jul 25
Aug 25
Nov 25
Strong Buy
3
4
3
4
5
Buy
0
0
0
0
1
Hold
2
1
2
1
1
Sell
8
6
6
0
0
Strong Sell
0
0
0
0
0
total
13
11
11
5
7
In the current month, NXTC has received 6Buy Ratings, 1Hold Ratings, and 0Sell Ratings. NXTC average Analyst price target in the past 3 months is 17.67.
Each month's total comprises the sum of three months' worth of ratings.
NXTC Financial Forecast
NXTC Earnings Forecast
Next quarter’s earnings estimate for NXTC is -$2.66 with a range of -$3.46 to -$2.14. The previous quarter’s EPS was -$3.22. NXTC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year NXTC has Performed in-line its overall industry.
Next quarter’s earnings estimate for NXTC is -$2.66 with a range of -$3.46 to -$2.14. The previous quarter’s EPS was -$3.22. NXTC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year NXTC has Performed in-line its overall industry.
NXTC Sales Forecast
Next quarter’s sales forecast for NXTC is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. NXTC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year NXTC has Performed in-line its overall industry.
Next quarter’s sales forecast for NXTC is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. NXTC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year NXTC has Performed in-line its overall industry.
NXTC Stock Forecast FAQ
What is NXTC’s average 12-month price target, according to analysts?
Based on analyst ratings, NextCure Inc’s 12-month average price target is 17.67.
What is NXTC’s upside potential, based on the analysts’ average price target?
NextCure Inc has 65.14% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is NXTC a Buy, Sell or Hold?
NextCure Inc has a consensus rating of Strong Buy which is based on 3 buy ratings, 0 hold ratings and 0 sell ratings.
What is NextCure Inc’s price target?
The average price target for NextCure Inc is 17.67. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $20.00 ,the lowest forecast is $15.00. The average price target represents 65.14% Increase from the current price of $10.7.
What do analysts say about NextCure Inc?
NextCure Inc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 3 Wall Streets Analysts.
How can I buy shares of NXTC?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.